Journal: Oncology Reports
Article Title: PARG regulates the proliferation and differentiation of DCs and T cells via PARP/NF-κB in tumour metastases of colon carcinoma
doi: 10.3892/or.2019.7051
Figure Lengend Snippet: CD11c + CD11b + DCs in the spleen and liver of various groups (×200). (A) CD11c antigen expressed on the cell membrane as green fluorescence with FITC staining, CD11b antigen expressed on the cell membrane as emerged red fluorescence with Cy3 staining, CD11c and CD11b antigens co-expressed on the membrane as yellow fluorescence with FITC and Cy3 dual staining. (B) CD11c antigen expressed on the cell membrane as green fluorescence with FITC staining, CD11b antigen expressed on the cell membrane as red fluorescence with Cy3 staining, CD11c and CD11b antigens co-expressed on the membrane as yellow fluorescence with FITC and Cy3 dual staining. (C) Number of CD11c + CD11b + DCs in the spleen and liver of various groups, with a significant increase in the PARG-silenced group compared with that in the non-transfected or transfected with empty vector group. *P<0.05 vs. control groups. The silenced PARG in CT26 cells could promote the distribution of B220 + DEC205 + DCs in CT26 liver metastases and CT26 spleen inoculated tumours. DC, dendritic cell; FITC, fluorescein isothiocyanate; Cy3, cyanine 3; PARG, poly(ADP-ribose) glycohydrolase.
Article Snippet: The spleen or liver sections were first incubated with anti-DEC205 antibody (cat. no. ab51820; 1:50 diluted in PBS; Abcam, Cambridge, MA, USA) or anti-CD11b antibody (cat. no. sc-1186; 1:50 diluted in PBS; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), followed by the addition of anti-B220 antibody (cat. no. bs-10599R; 1:100 diluted in PBS; BIOSS, Beijing, China) or anti-CD11c antibody (cat. no. bs-2508R; 1:50 diluted in PBS; BIOSS) at 4°C overnight.
Techniques: Fluorescence, Staining, Transfection, Plasmid Preparation